⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6285291 | 1.00 | — | — | |
| SCHEMBL5736275 | 0.80 | SLC1A2 (0.36) | — | |
| SCHEMBL11580984 | 0.80 | SLC1A2 (0.36) | — | |
| SCHEMBL11581422 | 0.80 | SLC1A2 (0.36) | — | |
| SCHEMBL6340460 | 0.78 | CTSK (0.36) | — | |
| SCHEMBL28886655 | 0.77 | SLC1A2 (0.34) | — | |
| SCHEMBL7235467 | 0.76 | — | — | |
| SCHEMBL7235464 | 0.76 | — | — | |
| SCHEMBL600487 | 0.76 | — | — | |
| SCHEMBL10495982 | 0.76 | MCL1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10464958-B2 | Method for the synthesis of alpha-aminoalkylenephosphonic acid | MONSANTO TECHNOLOGY LLC (US) | 2019-11-05 | — | — | US | claimed |
| US-20180346497-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | MONSANTO TECHNOLOGY LLC (US) | 2018-12-06 | — | — | US | claimed |
| US-20150232493-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | MONSANTO TECHNOLOGY LLC | 2015-08-20 | — | — | US | claimed |
| EP-2875035-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | Straitmark Holding AG (CH) | 2015-05-27 | — | — | EP | claimed |
| WO-2014012990-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | STRAITMARK HOLDING AG (CH) | 2014-01-23 | — | — | WO | claimed |
| US-6329502-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | JAPAN ENERGY CORPORATION (JP) | 2001-12-11 | — | — | US | claimed |
| US-6313094-B1 | COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | JAPAN ENERGY CORPORATION (JP) | 2001-11-06 | — | — | US | claimed |
| EP-0635026-A1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | BIOCHEM PHARMA INC (CA) | 1995-01-25 | — | — | EP | claimed |
| WO-1993020100-A1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | BIOCHEM PHARMA INC. (CA) | 1993-10-14 | — | — | WO | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-10464958-B2 | Method for the synthesis of alpha-aminoalkylenephosphonic acid | MONSANTO TECHNOLOGY LLC (US) | 2019-11-05 | — | — | US | disclosed |
| US-20180346497-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | MONSANTO TECHNOLOGY LLC (US) | 2018-12-06 | — | — | US | disclosed |
| US-20150232493-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | MONSANTO TECHNOLOGY LLC | 2015-08-20 | — | — | US | disclosed |
| EP-2875035-A1 | METHOD FOR THE SYNTHESIS OF ALPHA-AMINOALKYLENEPHOSPHONIC ACID | Straitmark Holding AG (CH) | 2015-05-27 | — | — | EP | disclosed |
| US-6329502-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | JAPAN ENERGY CORPORATION (JP) | 2001-12-11 | — | — | US | disclosed |
| US-6313094-B1 | COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | JAPAN ENERGY CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| US-5688771-A | Lipophilic oligopeptides with immunomodulating activity | BIOCHEM PHARMA INC. (CA) | 1997-11-18 | — | — | US | disclosed |
| EP-0635026-A1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | BIOCHEM PHARMA INC (CA) | 1995-01-25 | — | — | EP | disclosed |
| WO-1993020100-A1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | BIOCHEM PHARMA INC. (CA) | 1993-10-14 | — | — | WO | disclosed |
| EP-0490667-A2 | HIV protease inhibitors | JAPAN ENERGY CORPORATION (JP) | 1992-06-17 | — | — | EP | disclosed |